Introduction The U.S. Food and Drug Administration has approved the first FDA gene therapy for inherited deafness, a one-time treatment that restored measurable hearing in 80% of evaluable pediatric patients during clinical testing. The therapy, marketed as Otarmeni (lunsotogene parvec-cwha), targets a specific genetic cause of profound hearing loss tied to mutations in the OTOF gene. The decision marks the...
May 7, 2026
LATEST NEWS
The Deaths of Despair: Part II of The Missing Generation
Editor’s Note: This is not a position piece on mental health policy, drug enforcement, or the underlying causes of addiction and despair. It is a mathematical observation about the compounding demographic and fiscal impact on nations. The numbers are the numbers — what we do with them is the conversation. If you or someone you know is struggling, the 988...
The Missing Generation: How 200 Million Lost Lives Reshaped the West
Editor’s Note: This is not a position piece on abortion or the right to choose. It is a mathematical observation about the demographic and fiscal impact on nations. The numbers are the numbers — what we do with them is the conversation. The numbers don’t lie, even when polite society wishes they would. Since 1980, the United States has recorded...
DAILY FEED
Local Sports
FEATURED STORIES
FDA Approves First Gene Therapy for Inherited Deafness: What Otarmeni Means for Patients, Medicine, and Deaf Culture
Introduction The U.S. Food and Drug Administration has approved the first FDA gene therapy for inherited deafness, a one-time treatment...
The Deaths of Despair: Part II of The Missing Generation
Editor’s Note: This is not a position piece on mental health policy, drug enforcement, or the underlying causes of addiction...
The Missing Generation: How 200 Million Lost Lives Reshaped the West
Editor’s Note: This is not a position piece on abortion or the right to choose. It is a mathematical observation...
Inside the Arabella Advisors Network: The Dark Money Architecture Behind American Progressive Causes
Inside the Arabella Advisors Network: The Dark Money Architecture Behind American Progressive Causes In November 2025, the Washington, D.C. consulting...
How Far Does It Go? The Wider History of Nonprofits Paying Informants Inside Extremist Groups
How Far Does It Go? The Wider History of Nonprofits Paying Informants Inside Extremist Groups The April 21, 2026 federal...
Chorus Program Draws Scrutiny as U.S. Lawmakers Probe Influencer Payments by Sixteen Thirty Fund
A network of progressive influencers funded through a nonprofit tied to hundreds of millions of dollars in political spending is...
SPLC Indictment Tests Limits of Fraud Law in Nonprofit Intelligence Work
A federal indictment against the Southern Poverty Law Center is testing the legal boundaries of how nonprofits operate behind the...
Carbon Credits Market Matures in 2026 as Article 6 and Core Carbon Principles Reshape Voluntary Trading
After more than a decade of credibility problems, the global market for carbon credits has entered a markedly different phase...